Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Finding Critical Values for Chi-Square01:18

Finding Critical Values for Chi-Square

Consider a curve representing sample data drawn randomly from a normally distributed population. One must construct confidence intervals to estimate or to test a claim regarding the population standard deviation. For example, a 95% confidence interval covers 95% of the area under the curve, and the remaining 5% is equally distributed on either side of the curve. To achieve such confidence intervals, one must determine the critical values. The critical values are simply the values separating the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The hazards of using hazard ratios from proportional hazard models in indirect treatment comparisons.

Research synthesis methods·2026
Same author

Optical control of the cardiac rhythm with photoswitchable Na<sub>V</sub>1.5 channel blockers.

Nature communications·2026
Same author

Correction: Surface-enhanced confocal Raman microscopy to characterize esophageal cancer cell-derived extracellular vesicles and maternal cells.

Analytical methods : advancing methods and applications·2026
Same author

Safety and efficacy of fordadistrogene movaparvovec in ambulatory participants with Duchenne muscular dystrophy (CIFFREO): a phase 3, double-blind, randomised, placebo-controlled study.

The Lancet. Neurology·2026
Same author

Bayesian randomized basket trial design: a case study from the ultra-rare invasive mold infections.

Biometrics·2026
Same author

Remimazolam mitigates cerebral ischemia/reperfusion injury by concurrently alleviating damage to the blood-brain barrier and RIP3/MLKL-driven necroptosis.

International immunopharmacology·2026
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Fiducial-Based Statistical Intervals for Bounded Bioanalytical Data Using the Kumaraswamy Distribution.

Jorge Quiroz1, Jingwei Xiong1, Satrajit Roychoudhury2

  • 1Merck & Co., Inc., Rahway, New Jersey, USA.

Pharmaceutical Statistics
|May 19, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical method using the Kumaraswamy distribution for analyzing bounded biological data common in biopharmaceutical development. The approach provides more precise confidence and prediction intervals for skewed data, improving Chemical, Manufacturing, and Controls (CMC) applications.

Keywords:
fiducial prediction intervalsfiducial‐type tolerance intervalsgeneralized fiducial inferencegeneralized pivotal quantities

More Related Videos

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci
11:09

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci

Published on: January 25, 2011

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

Related Experiment Videos

Last Updated: May 20, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci
11:09

An Analytical Tool-box for Comprehensive Biochemical, Structural and Transcriptome Evaluation of Oral Biofilms Mediated by Mutans Streptococci

Published on: January 25, 2011

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms
15:27

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Published on: April 17, 2017

Area of Science:

  • Statistics
  • Biopharmaceutical Analysis
  • Data Science

Background:

  • Biological measurements (e.g., percent monomer, cell percentages) are continuous and bounded (0-1).
  • These data are often skewed, making normal-based statistical intervals inappropriate.
  • Existing transformation methods can yield overly wide intervals for skewed data.

Purpose of the Study:

  • To develop and evaluate new statistical methods for analyzing bounded, skewed biological data.
  • To provide more accurate and practical confidence, prediction, and tolerance intervals for CMC applications.
  • To introduce the Kumaraswamy distribution as a viable alternative for modeling bounded data.

Main Methods:

  • Development of two new pivotal quantities for the Kumaraswamy shape parameter alpha.
  • Integration with an existing pivotal quantity for beta.
  • Fiducial-based construction of statistical intervals (confidence, tolerance, prediction).
  • Simulation studies to assess finite-sample performance.
  • Comparison with existing pivotal methods and data transformations.

Main Results:

  • The proposed fiducial-based intervals using the Kumaraswamy distribution demonstrate practical utility.
  • The new method provides a flexible and mathematically tractable alternative to existing approaches.
  • Simulations indicate favorable performance compared to transformations and other pivotal methods, especially for skewed data.

Conclusions:

  • The Kumaraswamy distribution offers a robust model for bounded, skewed biological data in CMC.
  • The developed pivotal quantities enable accurate statistical interval construction.
  • The methods are recommended for routine use in biopharmaceutical bioanalytical practice for improved data analysis.